Should I Avoid nifedipine During Pregnancy? | VeriMom
Reviewed by VeriMom Editorial Team · Last reviewed
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
Pregnancy-safe products to use instead
Products built around the safer ingredients above, scored "no known risks" or "low risk".










Sources & references
Authoritative references used to score this ingredient.
Pregnancy-Safe Alternatives to nifedipine | VeriMom
Ingredients — Pregnancy-Safe Ingredients Database — 28,000+ Ingredients Rated
See also
FAQ
- Is nifedipine safe during pregnancy?
- Nifedipine is a systemic pharmaceutical (a dihydropyridine Ca2+ channel blocker) with evidence of fetal exposure: PBPK and clinical studies report substantial transplacental transfer (cord:maternal ratios ≈ ~1 in modelling and clinical measurements), and supplier safety data sheets list reproductive toxicity H361 (suspected of damaging fertility or the unborn child). Because ECHA-harmonised H360 classification was not identified but H361 is reported in SDS/registrations, hazard is scored as 'suspected' (h=2); mechanism is 'demonstrated' (m=2) because placental transfer and pharmacodynamic effects on uteroplacental blood flow are reported; topical cosmetic exposure is likely low but systemic if used as a drug, so for cosmetic topical use exposure is low (e=1). (Sources: PBPK and placental studies, systematic reviews and SDSs.).
- Is nifedipine safe while breastfeeding?
- Nifedipine is excreted into breastmilk in measurable but generally small amounts and is commonly considered compatible with breastfeeding in clinical guidance; supplier SDSs list reproductive toxicity H361 which supports a suspected reproductive hazard (h=2). Mechanistically, milk transfer is documented (so m=1–2), but adverse effects in infants are not robustly reported in the clinical literature; for topical cosmetic use exposure is expected to be low (e=1).
- Is nifedipine safe for baby skin?
- There is no infant-specific dermal hazard data for 0–3 yr; nifedipine is systemically active and can cross placenta / enter milk, so parental systemic concern remains (h=2). For baby skin, because infants have higher skin absorption and the parent compound is moderately lipophilic (not completely non-absorbable), increase exposure score by +1 relative to adult topical use (adult e=1 → infant e=2). No direct evidence supports increasing hazard or mechanism beyond adult data in absence of infant-specific studies.
- How does VeriMom score nifedipine?
- VeriMom scores nifedipine at 20/100 (high risk) based on EU CosIng status, ECHA hazard classifications, and peer-reviewed PubMed studies. Our scoring pipeline is fully transparent.
- What are pregnancy-safe alternatives to nifedipine?
- See our curated list of pregnancy-safe alternatives to nifedipine based on similar function and a no-known-risks safety band.
Check your own skincare
Paste any product's ingredient list into our free checker and see every ingredient scored against EU regulatory data and peer-reviewed research.
Open the pregnancy-safe ingredient checkerCheck every label in 2 seconds
Get VeriMom free — scan any product and see the pregnancy safety score instantly.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Safety scores are based on publicly available data and may not reflect all risks. Always consult your healthcare provider before using any product during pregnancy or breastfeeding.